Supernus Pharmaceuticals Inc. Common Stock is a leading specialty pharmaceutical company that develops and commercializes innovative products for the treatment of central nervous system diseases. With a focus on epilepsy and attention-deficit hyperactivity disorder, Supernus is dedicated to improving the lives of patients through its cutting-edge therapies and novel drug delivery technologies.
- Latest
- Trending
